Down-regulation of Dickkopf 3, a regulator of the Wnt signalling pathway, in elderly schizophrenic subjects

Journal of Neurochemistry

Volumn 94, Issue 2, 2005, Pages 520-530

  Ftouh, Saoussen ^a   Akbar, Mohammed T ^a   Hirsch, Steven R ^a   De Belleroche, Jacqueline S ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Dkk3; Gene expression; Neurodevelopment; Schizophrenia; Wnt signalling

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; WNT PROTEIN;

ADULT; AGED; ARTICLE; BRAN; CLINICAL ARTICLE; CONTROLLED STUDY; DKK3 GENE; DNA SEQUENCE; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION REGULATION; GERIATRIC PATIENT; HUMAN; IN SITU HYBRIDIZATION; MALE; MENTAL PATIENT; PRIORITY JOURNAL; PSYCHOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SLOT BLOT HYBRIDIZATION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; TEMPORAL CORTEX;

ADULT; AGED; AGED, 80 AND OVER; AUTORADIOGRAPHY; BLOTTING, NORTHERN; CASE-CONTROL STUDIES; CLONING, MOLECULAR; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; TEMPORAL LOBE; WNT PROTEINS;

EID: 22244448955     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03239.x     Document Type: Article

References (48)

1. Akbar M. T., Wells D. J., Latchman D. S. and de Belleroche J. (2001) Heat shock protein 27 shows a distinctive widespread spatial and temporal pattern of induction in CNS glial and neuronal cells compared to heat shock protein 70 and caspase 3 following kainate administration. Mol. Brain Res. 93, 148-163.
2. Brannan C. I., Decs E. C., Ingram R. S. and Tilghman S. M. (1990) The product of the H19 gene may function as an RNA. Mol. Cell. Biol. 10, 28-36.
3. Cao W., Epstein C., Liu H. et al. (2004) Comparing gene discovery from Affymetrix GeneChip micoarrays and Clontech PCR-select cDNA subtraction: a case study. BMC Genomics 5, 26-35.
4. Caricasole A., Ferraro T., Iacovelli L., Barletta E., Caruso A., Melchiorri D., Terstappen G. C. and Nicoletti F. (2003) Functional characterization of WNT7A signaling in PC12 cells: interaction with A FZD5 × LRP6 receptor complex and modulation by Dickkopf proteins. J. Biol. Chem. 278, 37024-37031.
5. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
6. Chowdari K. V., Mimics K., Seinwal P. et al. (2002) Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet. 11, 1373-1380.
7. Cotter D., Kerwin R., al Sarraji S., Brion J. P., Chadwich A., Lovestone S., Anderton B. and Everall I. (1998) Abnormalities of Wnt signalling in schizophrenia - evidence for neurodevelopmental abnormality. Neuroreport 9, 1379-1383.
8. Diatchenko L., Lau Y. F., Campbell A. P. et al. (1996) Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. USA 93, 6025-6030.
9. Elkin A., Kalidindi S. and McGuffin P (2004) Have schizophrenia genes been found? Curr. Opin. Psychiatry 17, 107-113.
10. Fedi P, Bafico A., Nieto S. A., Burgess W. H., Miki T., Bottaro D. P, Kraus M. H. and Aaronson S. A. (1999) Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling. J. Biol. Chem. 274, 19 465-19 472.
11. Hakak Y., Walker J. R., Li C., Wong W. H., Davis K. L., Buxbaum J. D., Haroutunian V. and Fienberg A. A. (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl Acad. Sci. USA 98, 4746-4751.
12. Harrison P. J. (1999) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122, 593-624.
13. Haug J. O. ( 1982) Pneumoencephalographic evidence of brain atrophy in acute and chronic schizophrenic patients. Acta Psychiatr. Scand. 66, 374-383.
14. Herken H. and Erdal M. E. (2001) Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis. Psychiatr. Genet. 11, 105-109.
15. Hoang B. H., Kubo T., Healey J. H., Yang R., Nathan S. S., Kolb E. A., Mazza B., Meyers P. A. and Gorlick R. (2004) Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catcnin pathway. Cancer Res. 64, 2734-2739.
16. Humphries C., Mortimer A., Hirsch S. and de Belleroche J. (1996) NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. Neuroreport 7, 2051-2055.
17. Johnstone E. C., Crow T. J., Frith C. D., Husband J. and Kreel L. (1976) Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet ii, 924-926.
18. Kozlovsky N., Belmaker R. H. and Agam G. (2000) Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am. J. Psychiatry 157, 831-833.
19. Kozlovsky N., Belmaker R. H. and Agam G. (2001 ) Low GSK-3 activity in frontal cortex of schizophrenic patients. Schizophr Res. 52, 101-105.
20. Kozlovsky N., Shanon-Weickert C., Tomaskovic-Crook E., Kleinman J. E., Belmaker R. H. and Agam G. (2004) Reduced GSK-3beta mRNA levels in post mortem dorsolateral prefrontal cortex of schizophrenic patients. J. Neural Transm. 111, 1583-1592.
21. Krupnik V. E., Sharp J. D., Jiang C. et al. (1999) Functional and structural diversity of the human Dickkopf gene family. Gene 238, 301-313.
22. Lewis D. A. and Lieberman J. A. (2000) Catching up on schizophrenia: natural history and neurobiology. Neuron 28, 325-334.
23. Ligon A. H., Pershouse M. A., Jasser S. A., Yung W. K. and Steck P. A. (1997) Identification of a novel gene product, R1G, that is down-regulated in human glioblastoma. Oncogene 14, 1075-1081.
24. Lijam N., Paylor R., McDonald M. P. et al. (1997) Social interaction and sensorimotor gating abnormalities in mice lacking Dv11. Cell 90, 895-905.
25. Lim K. O., Rosenbloom M. J., Faustman W. O., Sullivan E. V. and Pfefferbaum (1999) Cortical grey matter deficit in patients with bipolar disorder. Schizophrenia Res. 40, 219-227.
26. Lukyanov K. A., Launer G. A., Tarabykin V. S., Zaraisky A. G. and Lukyanov S. A. (1995) Inverted terminal repeats permit the average length of amplified DNA fragments to be regulated during preparation of cDNA libraries by polymerase chain reaction. Anal. Biochem. 229, 198-202.
27. Mao B., Wu W., Li Y., Hoppe D., Stannek P., Glinka A. and Niehrs C. (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411, 321-325.
28. McKenna P. J. (1997) Schizophrenia and Related Syndromes. Psychology Press, London, UK.
29. Mimmack M. L., Ryan M., Baba H. et al. (2002) Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc. Natl. Acad. Sci. USA 99, 4680-4685.
30. Mimics K., Middleton F. A., Marquez A., Lewis D. A. and Levitt P. (2000) Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 53-67.
31. Mimics K., Middleton F. A., Stanwood G. D., Lewis D. A. and Levitt P. (2001 ) Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry 6, 293-301.
32. Miyaoka T., Seno H. and Ishino H. (1999) Increased expression of Wnt-1 in schizophrenic brains. Schizophr. Res. 38, 1-6.
33. Mukhopadhyay M., Shtrom S., Rodriguez-Esteban C. et al (2001) Dickkopfl is required for embryonic head induction and limb morphogenesis in the mouse. Dev. Cell 1, 423-434.
34. Nelson M. D., Saykin A. J., Flashman L. A. and Riordan H. J. (1998) Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch. Gen. Psychiatry 55, 433-440.
35. Patapoutian A. and Reichardt L. F. (2000) Roles of Wnt proteins in neural development and maintenance. Curr. Opin. Neurobiol. 10, 392-399.
36. Peirson S. N., Butler J. N. and Foster R. G. (2003) Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res. 31, e73.
37. Prabakaran S., Swatton J. E., Ryan M. M. et al. (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 9, 684-697.
38. Roy P. D., Zipursky R. B., Saint-Cyr J. A., Langevin R. and Seeman M. (1998) Temporal horn enlargement in schizophrenia and bipolar disorder. Biol. Psychiatry 44, 418-422.
39. Sagerström C. G., Sun B. I. and Sive H. L. (1997) Subtractive cloning: past, present, and future. Annu. Rev. Biochem. 66, 751-783.
40. Shenton M. E., Dickey C. C., Frumin M. and McCarley R. W. (2001) A review of MRI findings in schizophrenia. Schizophr. Res. 49, 1-52.
41. Stefansson H., Sigurdsson E., Steinthorsdottir V. et al. (2002) Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892.
42. Straub R. E., Jiang Y., MacLean C. J. et al. (2002) Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 71, 337-348.
43. Tsuji T., Nozaki I., Miyazaki M., Sakaguchi M., Pu H., Hamazaki Y., Lijima O. and Namba M. (2001) Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas. Biochem. Biophys. Res. Commun. 289, 257-263.
44. Vawter M. P., Barrett T., Cheadle C., Sokolov B. P., Wood W. H. III, Donovan D. M., Webster M., Freed W. J. and Becker K. G. (2001) Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res. Bull. 55, 641-650.
45. Virgo L., Humphries C., Mortimer A., Barnes T., Hirsch S. and de Belleroche J. (1995) Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia. Biol. Psychiatry 37, 694-701.
46. Wodarz A. and Nusse R. (1998) Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14, 59-88.
47. Wong A. H. and Van Tol H. H. (2003) Schizophrenia: from phenomenology to neurobiology. Neurosci. Biobehav. Rev. 27, 269-306.
48. Yang J., Si T., Ling Y. et al. (2003) Association study of the human FZD3 locus with schizophrenia. Biol. Psychiatry 54, 1298-1301.